These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 20422276)

  • 1. Why not treat human cancer with interleukin-1 blockade?
    Dinarello CA
    Cancer Metastasis Rev; 2010 Jun; 29(2):317-29. PubMed ID: 20422276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating inflammation by blocking interleukin-1 in humans.
    Dinarello CA; van der Meer JW
    Semin Immunol; 2013 Dec; 25(6):469-84. PubMed ID: 24275598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of interleukin-1 antagonists in rheumatoid arthritis: a systematic review and meta-analysis.
    Nikfar S; Saiyarsarai P; Tigabu BM; Abdollahi M
    Rheumatol Int; 2018 Aug; 38(8):1363-1383. PubMed ID: 29737371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is IL-1 a good therapeutic target in the treatment of arthritis?
    Burger D; Dayer JM; Palmer G; Gabay C
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):879-96. PubMed ID: 16980212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
    Abramson SB; Amin A
    Rheumatology (Oxford); 2002 Sep; 41(9):972-80. PubMed ID: 12209029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies.
    Cavalli G; Dinarello CA
    Rheumatology (Oxford); 2015 Dec; 54(12):2134-44. PubMed ID: 26209330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease modifying and antiangiogenic activity of 2-methoxyestradiol in a murine model of rheumatoid arthritis.
    Plum SM; Park EJ; Strawn SJ; Moore EG; Sidor CF; Fogler WE
    BMC Musculoskelet Disord; 2009 May; 10():46. PubMed ID: 19409094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis.
    Kalliolias GD; Liossis SN
    Expert Opin Investig Drugs; 2008 Mar; 17(3):349-59. PubMed ID: 18321234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis.
    Cohen SB
    Rheum Dis Clin North Am; 2004 May; 30(2):365-80, vii. PubMed ID: 15172046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.
    Leite de Oliveira R; Hamm A; Mazzone M
    Mol Aspects Med; 2011 Apr; 32(2):71-87. PubMed ID: 21540050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of soluble apoptotic markers with impaired left ventricular deformation in patients with rheumatoid arthritis. Effects of inhibition of interleukin-1 activity by anakinra.
    Ikonomidis I; Tzortzis S; Lekakis J; Paraskevaidis I; Dasou P; Parissis J; Nikolaou M; Markantonis SL; Katsimbri P; Skarantavos G; Andreadou I; Anastasiou-Nana M
    Thromb Haemost; 2011 Nov; 106(5):959-67. PubMed ID: 21947196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting rheumatoid tenosynovial angiogenesis with cytokine inhibitors.
    Jain A; Kiriakidis S; Brennan F; Sandison A; Paleolog E; Nanchahal J
    Clin Orthop Relat Res; 2006 May; 446():268-77. PubMed ID: 16456308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1 inhibitors: novel agents in the treatment of rheumatoid arthritis.
    Gabay C
    Expert Opin Investig Drugs; 2000 Jan; 9(1):113-27. PubMed ID: 11060665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer.
    Lindahl G; Saarinen N; Abrahamsson A; Dabrosin C
    Cancer Res; 2011 Jan; 71(1):51-60. PubMed ID: 21097717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis.
    Coxon A; Bolon B; Estrada J; Kaufman S; Scully S; Rattan A; Duryea D; Hu YL; Rex K; Pacheco E; Van G; Zack D; Feige U
    Arthritis Rheum; 2002 Oct; 46(10):2604-12. PubMed ID: 12384918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actual status of antiinterleukin-1 therapies in rheumatic diseases.
    Geyer M; Müller-Ladner U
    Curr Opin Rheumatol; 2010 May; 22(3):246-51. PubMed ID: 20150813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained delivery of IL-1 Ra from biodegradable microspheres reduces the number of murine B16 melanoma lung metastases.
    Lavi G; Voronov E; Dinarello CA; Apte RN; Cohen S
    J Control Release; 2007 Nov; 123(2):123-30. PubMed ID: 17900737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways.
    Liu C; He L; Wang J; Wang Q; Sun C; Li Y; Jia K; Wang J; Xu T; Ming R; Wang Q; Lin N
    J Ethnopharmacol; 2020 Oct; 260():113039. PubMed ID: 32497675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of anakinra, a recombinant interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis and comparison to anti-TNF-alpha agents.
    Fleishmann RM
    Clin Exp Rheumatol; 2002; 20(5 Suppl 27):S35-41. PubMed ID: 14989428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.